"Citron's reports are a lot more fun to read than just about anything published by a mainstream Wall Street stock analyst."
-- Bloomberg News

Nov. 14, 2015
HomeReportsArchivesContact Us / SuggestionsLegal DisclaimerWho is Citron

Intuitive Surgical: AMA Editorial and New Lawsuit a Must Read for Investors … and Patients

Posted in Citron Reports by Stocklemon on the February 21st, 2013

  Citron White Bkgd Citron reaffirms its $300 price target on Intuitive Surgical (NYSE:ISRG)

Journal of the AMA study – plus a devastating new lawsuit expose the dark secrets behind the dramatic rise in robotic surgeries….and foretell its end.

This is NOT a story of shorts vs Intuitive Surgical.  

This is a story of the American Medical Association, the Affordable Health Care Act, and tort law vs Intuitive Surgical.

Click here for the entire report.

9 queries in 0.209 seconds